Literature DB >> 29209981

The Effect of Frailty Index on Early Outcomes after Combined Colorectal and Liver Resections.

Sophia Y Chen1, Miloslawa Stem1, Marcelo Cerullo1, Susan L Gearhart1, Bashar Safar1, Sandy H Fang1, Matthew J Weiss1, Jin He1, Jonathan E Efron2.   

Abstract

BACKGROUND: Although previous studies have examined frailty as a potential predictor of adverse surgical outcomes, little is reported on its application. We sought to assess the impact of the 5-item modified frailty index (mFI) on morbidity in patients undergoing combined colorectal and liver resections.
METHODS: Adult patients who underwent combined colorectal and liver resections were identified using the ACS-NSQIP database (2005-2015). The 5-item mFI consists of history of chronic obstructive pulmonary disease, congestive heart failure, hypertension, diabetes, and partial/total dependence. Patients were stratified into three groups: mFI 0, 1, or ≥ 2. The impact of the mFI on primary outcomes (30-day overall and serious morbidity) was assessed using multivariable logistic regression. Subgroup analyses by age and hepatectomy type was also performed.
RESULTS: A total of 1928 patients were identified: 55.1% with mFI = 0, 33.2% with mFI = 1, and 11.7% with mFI ≥ 2. 75.9% of patients underwent wedge resection/segmentectomy (84.6% colon, 15.4% rectum), and 24.1% underwent hemihepatectomy (88.8% colon, 11.2% rectum). On unadjusted analysis, patients with mFI ≥ 2 had significantly greater rates of overall and serious morbidity, regardless of age and hepatectomy type. These findings were consistent with the multivariable analysis, where patients with mFI ≥ 2 had increased odds of overall morbidity (OR 1.41, 95% CI 1.02-1.96, p = 0.037) and were more than twice likely to experience serious morbidity (OR 2.12, 95% CI 1.47-3.04, p < 0.001).
CONCLUSIONS: The 5-item mFI is significantly associated with 30-day morbidity in patients undergoing combined colorectal and liver resections. It is a tool that can guide surgeons preoperatively in assessing morbidity risk in patients undergoing concomitant resections.

Entities:  

Keywords:  Frailty index; Morbidity; Mortality; Synchronous colorectal liver metastasis

Mesh:

Year:  2017        PMID: 29209981     DOI: 10.1007/s11605-017-3641-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  6 in total

1.  The Association of Frailty with Outcomes after Cancer Surgery: A Systematic Review and Metaanalysis.

Authors:  Julia F Shaw; Dan Budiansky; Fayza Sharif; Daniel I McIsaac
Journal:  Ann Surg Oncol       Date:  2022-01-24       Impact factor: 5.344

2.  The Impact of Frailty on Patients Undergoing Liver Resection for Colorectal Liver Metastasis.

Authors:  Jacqueline Dauch; Mohammad Hamidi; Amanda K Arrington; Catherine L O'Grady; Chiu-Hsieh Hsu; Bellal Joseph; Taylor S Riall; Mohammad Khreiss
Journal:  J Gastrointest Surg       Date:  2021-09-20       Impact factor: 3.452

3.  Development and Performance of a Clinical Decision Support Tool to Inform Resource Utilization for Elective Operations.

Authors:  Benjamin A Goldstein; Marcelo Cerullo; Vijay Krishnamoorthy; Jeanna Blitz; Leila Mureebe; Wendy Webster; Felicia Dunston; Andrew Stirling; Jennifer Gagnon; Charles D Scales
Journal:  JAMA Netw Open       Date:  2020-11-02

4.  The composite risk index based on frailty predicts postoperative complications in older patients recovering from elective digestive tract surgery: a retrospective cohort study.

Authors:  Chun-Qing Li; Chen Zhang; Fan Yu; Xue-Ying Li; Dong-Xin Wang
Journal:  BMC Anesthesiol       Date:  2022-01-03       Impact factor: 2.217

5.  The prevalence and prognostic value of frailty screening measures in patients undergoing surgery for colorectal cancer: observations from a systematic review.

Authors:  Josh McGovern; Ross D Dolan; Paul G Horgan; Barry J Laird; Donald C McMillan
Journal:  BMC Geriatr       Date:  2022-03-29       Impact factor: 3.921

6.  5-mFI is more accurate than ASA score in predicting postoperative mortality in rectal cancer: A case series of 109 patients.

Authors:  Mahdi Bouassida; Hazem Beji; Yessin Kallel; Mohamed Fadhel Chtourou; Houda Belfkih; Bacem Trabelsi; Hassen Touinsi
Journal:  Ann Med Surg (Lond)       Date:  2022-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.